Novo Nordisk reveals obesity drug with up to 22 percent weight loss
Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% as the drug exhibits safety and potential as a...
Tag : weight loss treatment
Novo Nordisk tops Tesla in market value with new obesity pill
Novo Nordisk edges past Tesla in market value on successful obesity pill trial. Danish company's shares soar....